Therapeutic Recommendations For The Treatment Of Children With A Retinoblastoma
NCT ID: NCT04425434
Last Updated: 2025-10-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
3000 participants
OBSERVATIONAL
2020-11-01
2029-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Photoscreening for Retinoblastoma
NCT04344652
Outcomes Study of Late Effects After Proton RT for Pediatric Tumors of the Brain, Head, and Neck
NCT01067196
Research on the Environment and Children's Health: Retinoblastoma
NCT00582049
Liver MRI With Primovist/Eovist in Pediatric Subjects Who Are Suspected or Have Focal Liver Lesions.
NCT01043523
Estimating Setup Uncertainty in Pediatric Proton Therapy Using Volumetric Images
NCT04125095
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
OBSERVATIONAL
We will look at the outcome of the the children treated to see if the survival is improved when these therapeutic measures are followed.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Unilateral extraocular intraorbital (RB)
* Bilateral intraocular (RB)
* bilateral intraocular (RB) on one side and extraocular but intraorbital on the other side.
Exclusion Criteria
* massive extension to optic nerve up to optical channeltumor
* intracranial extension leptomeninges
* cerebral parenchyma
* extension to regional lymph nodes and/or remote metastases.
* cerebrospinal fluid involvement.
* Trilateral RB
* Incapacity to followed the whole treatement.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
French Africa Pediatric Oncology Group
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
FOUSSEYNI Mr TRAORE, Dr;
Role: PRINCIPAL_INVESTIGATOR
AMCC AND GFAOP
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hopital Yalgado Ouedraogo
Ouagadougou, , Burkina Faso
CHU de Treichville à ABIDJAN
Abidjan, , Côte d’Ivoire
CUK (Cliniques Universitaires de Kinshasa)
Kinshasa, Kinshasa City, Democratic Republic of the Congo
Cliniques Universitaires de Lubumbashi (CUL)
Lubumbashi, , Democratic Republic of the Congo
HJRA, Hôpital universitaire Joseph Ravoahangy Andrianavalona
Antananarivo, Ampefiloha, Madagascar
CHU Gabriel Touré (HGT)
Bamako, , Mali
Hôpital Aristide Le Dantec,
Dakar, , Senegal
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Fatou-Binetou DIAGNE AKONDE, DR
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
GFAOP RB1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.